Recombinant 2019-nCoV 3C-like Proteinase (N-6His)
Recombinant 2019-nCoV 3C-like Proteinase (N-6His) from ELK Biotechnology Read more ›
Product Description
Recombinant 2019-nCoV 3C-like Proteinase (N-6His) is an ELK Biotechnology recombinant protein for research use.
Description
Recombinant 2019-nCoV 3C-like Proteinase is produced by our E.coli expression system and the target gene encoding Ser1-Gln306 is expressed with a 6His tag at the N-terminus.
Background
The viral main proteinase (M pro , also called 3CL pro ), which controls the activities of the coronavirus replication complex. It functions as a cysteine protease engaging in the proteolytic cleavage of the viral precursor polyprotein to a series of functional proteins required for coronavirus replication and is considered as an appealing target for designing anti-SARS agents.
Handling information
| Delivery condition | The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below. |
|---|
Key Facts
| Target | Recombinant 2019-nCoV 3C-like Proteinase |
| Also known as | M Proteinase; 3CL Proteinase |
| Purity | Greater than 95% as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized protein |
| Research area | Infectious Diseases, Molecular Biology |
| Specification | PURITY | ENDOTOXIN | BIOACTIVITY |
|---|---|---|---|
| Product QC |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Not intended for diagnostic or therapeutic use.